Somatic mutations in homologous recombination pathway predict favourable prognosis after immunotherapy across multiple cancer types

Clin Transl Med. 2021 Dec;11(12):e619. doi: 10.1002/ctm2.619.

Zaoqu Liu^{1

2

3}, Chunguang Guo⁴, Jing Li¹, Hui Xu^{1

2

3}, Taoyuan Lu⁵, Libo Wang⁶, Long Liu⁶, Xinwei Han^{1

2

3}

¹ Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
² Interventional Institute of Zhengzhou University, Zhengzhou, China.
³ Interventional Treatment and Clinical Research Center of Henan Province, Zhengzhou, China.
⁴ Department of Endovascular Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
⁵ Department of Cerebrovascular Disease, Zhengzhou University People's Hospital, Zhengzhou, China.
⁶ Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

No abstract available

Publication types